News / Taiwan / economic_daily
ABC-KY Revenue Surpasses 2023 Total in First Eight Months, Eyes Seasonal Growth
Health Technology · Biotechnology · economic_daily · 2026-09-10
6598
ABC-KY reported strong August revenue growth, exceeding its total 2023 performance in just eight months, driven by seasonal demand and expanded US market reach.
What Happened
Strong Financial Performance: ABC-KY announced August revenue of NT$60.94 million, a 64% year-on-year increase, bringing the year-to-date total to NT$535 million. This figure has already surpassed the company's total revenue for the entire previous year, reflecting successful market penetration and rising customer demand.
Seasonal Market Tailwinds: As the Northern Hemisphere enters the peak respiratory infection season, demand for diagnostic testing is expected to rise significantly. Analysts believe that ABC-KY's established presence in the US market positions it well to capitalize on this seasonal surge in testing requirements.
Strategic Market Expansion: The company is broadening its US footprint by partnering with major distributor Henry Schein to access medical center systems. By offering integrated respiratory and gastrointestinal testing solutions, ABC-KY aims to secure long-term contracts with large-scale laboratory clients.
Future Growth Prospects: ABC-KY is currently working with the FDA to incorporate COVID-19 testing into its existing respiratory molecular diagnostic panels. Securing regulatory approval for this expanded suite would further strengthen the company's competitive standing in the US laboratory testing market.